Access to Medicines
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
... Canada immediately responded to this decision in September 2003 and was the first country to announce that it would implement the agreement to facilitate greater access to affordable medicines for ...
15
Access to medicines for acute illness in middle income countries in Central America
... Treating an illness that was perceived to be severe was the strongest predictor of seeking health care (OR 2.6, 95%CI 1.9;3.4), according to the final logistic regression model (Table 2). Other significant predictors ...
12
Judicialization of access to medicines in four Latin American countries: a comparative qualitative analysis
... of access to medicines as a widespread phenomenon in their respective ...of access to medicines emerged in the four countries regardless of the constitutional protection or the health system ...
14
TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana
... This article focuses on Ghana, a developing country that recently changed its patent laws to conform to TRIPS standards. While Ghana has made strides in improving public health, the country has urgent and serious health ...
10
Corporate social responsibility to improve access to medicines: the case of Brazil
... the Access to Medicines Index (ATM), funded by the Gates Founda- tion, is gaining notice given that it ranks how well select companies are doing from a societal ...
11
An analysis of the determinants of access to medicines and health care in developing country settings
... While Ramsey‘s rule is proposed as a pricing solution for public authorities, it has been considered as a price setting rule from the perspective of the pharmaceutical industry to address inequities in access to ...
327
Implementing TRIPS in India : implications for access to medicines
... This thesis investigates the implications of implementing TRIPS in India for access to medicines drawing on three major factors; namely, (i) the TRIPS agreement, (ii), the globa[r] ...
342
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
... on medicines quality, security of supply and rationale ...all medicines and therefore could be used to analyse other therapeutic ...how medicines data can be systematically gathered at national ...
14
Canada and access to medicines in developing countries: intellectual property rights first
... Once the compromise around compulsory licensing was reached, Canada passed Bill C-9 in May 2004 thereby becoming the first country to pass legislation allowing for the production and export of generic drugs to coun- ...
8
Barriers in household access to medicines for chronic conditions in three Latin American countries
... to access to the formal health sec- tor and to medicines in three different settings in Latin America, and they suggest policies and strat- egies that could increase access to medicines and ...
14
A review of promoting access to medicines in China problems and recommendations
... for access to ...in medicines area are ...equal access to and cost-effective use of quality medicines in China, and maybe serve as a reference for other ...
9
Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
... to access to medicines and services, place sub- stantial and often catastrophic burden on individuals and their families, and also have proportionately regres- sive effects on the poor and the lowest wealth ...
11
The Best of Intentions: Why the Proposed Changes to the Canadian Access to Medicines Regime Should Not Be Implemented
... better access to medicines, as illustrated by Apotex’s experiences under the current ...better access to medicines is a vital purpose of the Doha Declaration, 151 countries should provide for ...
31
Access to medicines by child refugees in the East Midlands region of England: a cross sectional study
... presenting to the emergency department, our fi ndings may have been different. A small study in Ireland of 25 refugees found that 20% of refugees were not registered with a GP. 15 Additionally, we did not look at the ...
6
Measuring access to medicines: a review of quantitative methods used in household surveys
... different access dimen- sions such as availability, geographic accessibility and accommodation [9], we observed that such definition may include not only the medicine acquisition but also the cost-related underuse ...
8
The Access to Medicines: The Weak Link of the Exemption of Healthcare Payment Policy for the Elderly in Senegal
... free access to healthcare for the elderly translates a real political will of decision-makers to answer the sanitary concerns of this category of vulnerable ...free access to the Plan Sesame and to collect ...
6
Access to medicines for diabetes treatment in Brazil: evaluation of “health has no price” program
... Background: In 2011, private pharmacies associated to the Brazilian Ministry of Health provided patients with two types of insulin (regular human insulin and isophane insulin or NPH) and three oral antidiabetic ...
5
Impact of Access to Medicines on Public Health. Problems Associated with Access, Use, and Abuse of Antibiotics
... Circulation of low-quality or counterfeit antibiotics is another threat to the power of drugs and another source of resistance [24]. These products are prevalent in countries where drug regulatory authorities are weak ...
14
Access to medicines for hypertension: a survey in rural Yogyakarta province, Indonesia
... of medicines that was sufficient for less than 7 ...of medicines from Indonesian CHCs has been reported previously and indicates that there is a need to review the CHC policy regarding the provision of ...
13
The pharmacy of the developing world : India, patent law and access to essential medicines
... usefulness of compulsory licensing as a means of providing access to medicines. First of all, multinational brand-name pharmaceutical companies represented by Pharmaceutical Research and Manufacturers of ...
524